Status | Study |
Completed |
Study Name: Post-Marketing Surveillance of the Tanreqing Injection: a Real World Study Condition: Adverse Drug Reaction Drug Allergy Date: 2014-03-20 |
Recruiting |
Study Name: Management of Drug Hypersensitivity in Children Condition: Drug Hypersensitivity Date: 2014-01-05 |
Recruiting |
Study Name: Comparison Between Corticosteroid and Topical Steroids in the DRESS Condition: Drug Rash With Eosinophilia and Systemic Symptoms Date: 2013-09-17 Interventions: Drug: Prednisone |
Completed |
Study Name: The Diagnosis of Penicillin/Aminopenicillin Allergy in Thailand Condition: Penicillin Allergy Aminopenicillin Allergy Date: 2012-08-15 |
Recruiting |
Study Name: Quality of Life of Patients With a History of Drug Allergy in Thailand Condition: Quality of Life Date: 2012-08-12 Interventions: Other: Questionnaires DrHy-Q (Thai version) and WHOQOL-BREF-THAI will be asked |
Completed |
Study Name: Xenon Compared to Sevoflurane and Total Intravenous Anaesthesia for Coronary Artery Bypass Graft Surgery Condition: Coronary Artery Disease General Anesthetic Drug Allergy Date: 2011-02-09 Interventions: Drug: Xenon Inhaled xenon, max |
Terminated |
Study Name: Evaluation of TNF-α Blockade Effect in Patients With Severe Cutaneous Adverse Drug Reactions Condition: Drug Hypersensitivity Date: 2009-07-05 Interventions: Drug: anti-TNF a 25mg BIW, SC Other Name: Etanercept |
Withdrawn |
Study Name: Equivalency of Penicilloate Skin Test Reactivity Prepared by a Modified Alkaline Hydrolysis Technique Condition: Penicillin Allergy Date: 2007-12-28 Interventions: Other: penicillin skin test Prick skin tests will be perfo |
Completed |
Study Name: Study of Two Marketed Ocular Anti-Allergy Medications in Subjects With Allergic Conjunctivitis Condition: Allergic Conjunctivitis Date: 2007-09-20 Interventions: Drug: Elestat Elestat BID for |
Terminated |
Study Name: Treatment of Hypersensitivity Syndrome (DRESS) With Tegeline® (Human Immunoglobulin) Condition: Drug Hypersensitivity Date: 2007-07-20 Interventions: Drug: Tegeline® 2g/kg in IV on 2days 2g/kg in IV on 4days for patients with renal insufficiency or |